miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. - Wikidata - awgldk - TriplyDB

miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

http://www.wikidata.org/entity/Q39347043

about

Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications Cancer Stem Cell Hierarchy in Glioblastoma Multiforme Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications HypoxamiRs and cancer: from biology to targeted therapy MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4 Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition Modeling miRNA-mRNA interactions: fitting chemical kinetics equations to microarray data MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN.The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases MicroRNA regulation network in colorectal cancer metastasis MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis.Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis.miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.Regulation of cancer metastasis by microRNAs.Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression.Gene and microRNA transcriptional signatures of angiotensin II in endothelial cells miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing.Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.Impact of miRNA sequence on miRNA expression and correlation between miRNA expression and cell cycle regulation in breast cancer cells.Selective microRNA-Offset RNA expression in human embryonic stem cells Deep sequencing of RNA from three different extracellular vesicle (EV) subtypes released from the human LIM1863 colon cancer cell line uncovers distinct miRNA-enrichment signatures.MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing.Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.The roles of microRNAs in the regulation of tumor metastasis.MicroRNAs in apoptosis, autophagy and necroptosis Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.miR-210: fine-tuning the hypoxic response.Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.Circulating small non-coding RNA signature in head and neck squamous cell carcinoma MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.Hypoxia-regulated target genes implicated in tumor metastasis.

P2860

Q26747274-DD3CEF7F-6133-4548-B0C8-17F66B19B2EC Q26752312-21DA5024-4C62-4EF7-B266-BF646E2C65F2 Q26752753-59554937-411B-48BE-9DDD-D23BE149F176 Q26863298-2032EAAF-9C3A-4C71-B9E9-D557BB37D7E6 Q27022292-F50B8496-DE84-4FEB-8518-B5A465C4793A Q27024427-77D2DEC9-0B4C-468E-9E28-39EC049C84A9 Q27316708-D400934B-8857-4182-8932-B79A321CF084 Q28080346-84AC295E-35CD-4AAF-AC3B-929388B2CD6F Q30759466-1F71EE19-1953-44BB-9558-ED7E43EEC0E9 Q33755798-6F3EB8D5-9FDC-4EA8-BEFB-D57E638A348C Q34143922-D8B73207-9C34-4EBC-8162-7334EC9F86D2 Q34161573-CC0E18A2-F396-4A70-AABF-57A98951D667 Q34203585-036453D9-090C-40C3-866E-8E54D53A37BD Q34204974-9380EF2E-327A-4500-846F-78B084496D73 Q34491119-606545FB-96CE-4AE8-B60D-19541014CEDC Q34571945-8A395922-A11B-48CF-B539-443A28A94368 Q34623368-5A02F412-21B1-47CD-8FDB-00CC3A90486F Q34989307-79837285-354A-4B34-97D4-6A64C1C5EED8 Q35005275-0E4B21F2-2386-46F6-98B5-0E2F68851B19 Q35052860-76722584-8140-4051-AC8B-C35820FD8F1D Q35057280-A78F6D60-F4B3-4C37-905D-F08F111B85BF Q35069791-47AD7BEA-DBC1-4C3F-AB77-62C85AB33F58 Q35079173-FA0B2E6F-F78A-4870-B542-666D2C2AA964 Q35121518-2C5B77EC-EF2A-4144-9761-416559871D60 Q35153017-987D8052-BF6A-4E45-A439-1C8CC8A7CB58 Q35231184-84FCA50B-A76C-4743-A54F-65FA762BF58C Q35351470-43E582F0-4AFA-49B3-BFB9-15E69775B5D1 Q35622047-4B0A0C8D-7C50-4F07-9DD9-57EC795684FE Q35687197-85C81DA4-E0C1-4A2C-9478-24C46048323A Q35793846-174475DA-1BB6-4EA9-B3CB-C6170D344C53 Q35811250-63252628-521F-4147-A878-B9C24E814A8C Q35816884-A55C47C8-4A32-4698-9CD2-C640A0B76B7E Q35832148-E5323A93-A3DE-4D81-B121-A17B03A1BD13 Q35860856-EF006EA0-0F87-4DFC-88A7-10204BB97817 Q35891149-83CF0145-B1DA-4B87-AA9B-D7EC93D8AE81 Q36164325-4A255796-66CB-48CB-B02B-F71BF182CA60 Q36223500-67E24C14-1227-4067-8178-D6325B72BF3A Q36326374-D0921196-A0D5-4810-8318-E66E2648ACB2 Q36511384-6DE33548-D97C-4843-966F-F0C585ECDF20 Q36521763-AA81BE27-D66F-45E8-8E47-91A39E3EBFA2

P2860

miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

http://www.wikidata.org/entity/Q39347043

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@en

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@nl

type

label

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@en

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@nl

prefLabel

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@en

miR-103/107 promote metastasis ...... sis suppressors DAPK and KLF4.

@nl

P1433

Q39347043-BF98C04F-7653-427B-8723-DD0AB0B26B12

P1476

Q39347043-2CD5DC79-1442-4248-99BA-51652941A22B

P2093

Q39347043-1ACEA8AB-8EA8-4E02-890F-33D1B8A33C66

Q39347043-202FCF84-21AD-4387-BD7C-D056C5F9A1A6

Q39347043-2579E993-EF37-41E4-81B8-C002F8C68BE3

Q39347043-3782CB34-B43A-461C-98B3-5302B6D70E0F

Q39347043-391270CB-F267-4376-9D87-9158917F07BA

Q39347043-42F25A69-F298-4F11-AF3B-BEFA22927B20

Q39347043-470D01F0-2D27-4CE4-A739-C3FE10CFB9D4

Q39347043-5C282ABE-A2A1-4FB7-BADC-C0FA6C2D98DE

Q39347043-722CEF97-751E-400D-9C72-7717908EC0C6

Q39347043-8AB36C23-A926-46C9-BF5C-1E3B006D2396

P304

Q39347043-2AFC0C88-E156-4C8B-A3EF-022022081677

P31

Q39347043-5088635A-291A-41EA-A667-9924D7245DE9

P356

Q39347043-103853AE-1822-4594-A0D2-D57D5C7AEC46

P407

Q39347043-6692C2F6-D94B-47A8-9B20-0466F5D8FA1A

P433

Q39347043-D03C1132-4E23-40B0-B800-A237BE70B22F

P478

Q39347043-4EDDD29B-EEAF-4D2C-894A-71815F03E99C

P50

Q39347043-32243941-5799-4846-B243-6C97C3500F16

P577

Q39347043-BD362DF0-0AE5-42D2-B3B3-91F5BB98FEAF

P5875

Q39347043-AAA21577-E739-4259-82F3-C108D608F97C

P698

Q39347043-1372B443-6189-4E4C-9582-D876A138A8D3

P921

Q39347043-F9EA34E6-4672-42E9-B460-067C434B428D

P356

0008-5472.CAN-12-0667

P1433

Cancer Research

P1476

miR-103/107 promote metastasis ...... asis suppressors DAPK and KLF4

@en

P2093

Ching-Jung Lin

http://www.w3.org/2001/XMLSchema#string

Feng-Mao Lin

http://www.w3.org/2001/XMLSchema#string

Hsiang-Ching Chung

http://www.w3.org/2001/XMLSchema#string

Hsien-Da Huang

http://www.w3.org/2001/XMLSchema#string

Hsin-Yi Chen

http://www.w3.org/2001/XMLSchema#string

John Huang

http://www.w3.org/2001/XMLSchema#string

John Y-J Shyy

http://www.w3.org/2001/XMLSchema#string

Ruey-Hwa Chen

http://www.w3.org/2001/XMLSchema#string

Wei-Chi Wang

http://www.w3.org/2001/XMLSchema#string

Yaw-Dong Lang

http://www.w3.org/2001/XMLSchema#string

P304

3631-3641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-0667

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224972403

http://www.w3.org/2001/XMLSchema#string

P698

22593189

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer